TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial.

Richard T Penson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.